Does CAPLACIZUMAB-YHDP Cause Platelet count decreased? 126 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 126 reports of Platelet count decreased have been filed in association with CAPLACIZUMAB-YHDP. This represents 9.0% of all adverse event reports for CAPLACIZUMAB-YHDP.
126
Reports of Platelet count decreased with CAPLACIZUMAB-YHDP
9.0%
of all CAPLACIZUMAB-YHDP reports
4
Deaths
53
Hospitalizations
How Dangerous Is Platelet count decreased From CAPLACIZUMAB-YHDP?
Of the 126 reports, 4 (3.2%) resulted in death, 53 (42.1%) required hospitalization, and 1 (0.8%) were considered life-threatening.
Is Platelet count decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CAPLACIZUMAB-YHDP. However, 126 reports have been filed with the FAERS database.
What Other Side Effects Does CAPLACIZUMAB-YHDP Cause?
Product use in unapproved indication (465)
Adamts13 activity decreased (136)
Off label use (133)
Epistaxis (123)
Fatigue (110)
Contusion (86)
Injection site pain (74)
Headache (71)
Adamts13 activity abnormal (63)
Injection site bruising (63)
What Other Drugs Cause Platelet count decreased?
LENALIDOMIDE (7,491)
NIRAPARIB (4,102)
ELTROMBOPAG OLAMINE (3,419)
RUXOLITINIB (3,028)
RITUXIMAB (2,404)
VENETOCLAX (2,367)
DEXAMETHASONE (2,321)
PALBOCICLIB (2,277)
CYCLOPHOSPHAMIDE (1,894)
RIBAVIRIN (1,701)
Which CAPLACIZUMAB-YHDP Alternatives Have Lower Platelet count decreased Risk?
CAPLACIZUMAB-YHDP vs CAPMATINIB
CAPLACIZUMAB-YHDP vs CAPREOMYCIN
CAPLACIZUMAB-YHDP vs CAPSAICIN
CAPLACIZUMAB-YHDP vs CAPTOPRIL
CAPLACIZUMAB-YHDP vs CARBAMAZEPINE